Paula Lane
General Practice · Albuquerque, NMNPI 1740444561
Payments from drug & device makers
What this record shows
That places this record below the midpoint for general practice clinicians in NM, where the typical reported total is $251.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$1,060,249in research payments, 2019–2025
Across 153 payments — averaging $6929.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$488K
- Sage Therapeutics, LLC$416K
- Pfizer$84K
- Novo Nordisk AS$21K
- Teva Pharmaceuticals USA, Inc.$17K
- Modernatx, Inc.$14K
- plus $21K from 6 others
How this compares
$0 in reported general payments places this provider in the 0th percentile of 511 general practice providers in New Mexico.
Other general practice in Albuquerque
- Charles SchlesingerAlbuquerque$347K
- Sandra PaulesAlbuquerque$62K
- Alfred GiomboliniAlbuquerque$20K
- Robert KerschenAlbuquerque$20K
- Drew NewhoffAlbuquerque$17K
- Carissa Greinel-BlumAlbuquerque$13K
- Kendal TrujilloAlbuquerque$12K
- Devon RasmussenAlbuquerque$6K
- Ryan SillAlbuquerque$6K
- Colin FordeAlbuquerque$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.